Next, we tested whether 5-fluorouracil (5-FU), another anticancer agent often administered with OHP in tumor patients, but devoid of any peripheral neurotoxicity in clinical use as well as in this experimental study (see below), was also able to affect NHE activity and consequently to produce a cytosolic acidification in DRG neurons. This evidence concerns the gene SLC9C1 and neoplasm.